About FDA

FDA-TRACK Center for Biologics Evaluation & Research

Sign up to receive FDA-TRACK updates

CBER is the Center within FDA that regulates biological products for human use under applicable federal laws, including the Public Health Service Act and the Federal Food, Drug and Cosmetic Act. CBER protects and advances the public health by ensuring that biological products are safe and effective and available to those who need them. CBER also provides the public with information to promote the safe and appropriate use of biological products.

FDA-TRACK CBER Dashboard and Measures and Projects Index

Each FDA-TRACK program area collects, analyzes, and reports its performance measures and results. Updated performance measures and results are posted approximately 30 days after each quarterly briefing.

  • FDA-TRACK CBER Dashboard
    Each FDA-TRACK program area collects, analyzes, and reports its performance measures and results. Updated performance measures and results are posted approximately 30 days after each quarterly briefing.
  • FDA-TRACK CBER Measures and Projects Index
    List of all CBER measures and projects with charts of data and/or progress updates.

Subscribe

Sign up to receive FDA-TRACK updates

Page Last Updated: 05/23/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English